FDA releases compliance program for CDER, CDRH-led combination product inspections In a newly issued compliance program, the US Food and Drug Administration (FDA) explains its approach to inspections ...
The FDA Recalls Masterclass offers key learning for professionals to enhance recall preparation, compliance, and risk management strategies, minimizing financial impacts and corporate image damage ...
The Centers for Medicare and Medicaid Services (CMS) and the U.S. Food and Drug Administration (FDA) announced on Thursday ...
A study of routine good clinical practice (GCP) inspections between 2017 and 2023 found a declining number of Form 483s flagging violations at clinical trial sites and a very low number requiring ...
WASHINGTON (AP) — The Food and Drug Administration commissioner's effort to drastically shorten the review of drugs favored by President Donald Trump's administration is causing alarm across the ...
Amid an outpouring of industry investments in U.S. drug production, the FDA has launched a new program designed to significantly reduce the complexities involved in setting up domestic manufacturing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results